Position in DXCM
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$5,711,414
-$623,033 QoQ
Shares Held
84,802
-15.9% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#262
of 966 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Sterling Capital Management LLC holds $36,811,647 across 73 Medical Devices names. DXCM ranks #2 (15.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
207,301 | $18,810,492 | |
| 2 | DXCM |
Dexcom Inc
This page
|
84,802 | $5,711,414 | |
| 3 | MDT |
Medtronic plc
|
25,030 | $1,958,096 | |
| 4 | EW |
Edwards Lifesciences Corp
|
17,290 | $1,564,053 | |
| 5 | AORT |
Artivion, Inc.
|
48,906 | $1,098,917 | |
| 6 | PHG |
Koninklijke Philips NV
|
35,788 | $973,075 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
13,807 | $883,786 | |
| 8 | SIBN |
SI-BONE, Inc.
|
44,895 | $732,686 |
All Filings in DXCM
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,711,414 | 84,802 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $6,334,447 | 100,867 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $9,336,930 | 140,680 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $27,392,413 | 407,080 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $30,563,720 | 350,140 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $17,524,170 | 256,614 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $20,735,970 | 266,632 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $19,117,126 | 285,160 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||